Key considerations when prescribing midostaurin with a strong CYP3A4 inhibitor
Vložit
- čas přidán 6. 09. 2024
- Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.
Join our online communities to begin receiving free continuing medical education (CME) credit today!
Managing Myeloma: www.managingmye...
Managing Hodgkin Lymphoma: www.managinghod...
Managing MDS: www.managingmds...
Managing AML: www.managingaml...
Partners in Pancreatic Cancer: www.partnersinp......
The Practical Oncologist: www.practicalon...